Related Experiment Video
Updated: May 28, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Extended newborn screening: an update for the general paediatrician.
David Coman1, Kaustuv Bhattacharya
1Department of Metabolic Medicine, The Royal Children's Hospital, Brisbane, Queensland, Australia. david_coman@health.qld.gov.au
Journal of Paediatrics and Child Health
|October 25, 2011
Summary
Extended newborn screening (ENBS) using tandem mass spectrometry has reduced infant morbidity and mortality. This review examines the successes and challenges of ENBS programs in Australia and New Zealand.
Area of Science:
- Biochemistry
- Genetics
- Public Health
Background:
- Extended newborn screening (ENBS) is implemented nationwide in Australia and New Zealand.
- Tandem mass spectrometry is the core technology enabling ENBS.
Purpose of the Study:
- To review the successes of ENBS in reducing infant morbidity and mortality.
- To discuss the inherent and unforeseen challenges associated with ENBS.
Main Methods:
- Review of existing literature and program data on ENBS.
- Analysis of outcomes for specific screened conditions, e.g., medium-chain acyl-CoA dehydrogenase deficiency.
Main Results:
- ENBS has significantly reduced morbidity and mortality for certain inherited metabolic disorders.
- Implementation of ENBS presents various logistical and clinical challenges.
Conclusions:
- ENBS is a valuable public health tool with proven benefits.
- Addressing the challenges of ENBS is crucial for optimizing its effectiveness and sustainability.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...